基因专利的危险。
The perils of gene patents.
机构信息
McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
出版信息
Clin Pharmacol Ther. 2012 Jun;91(6):969-71. doi: 10.1038/clpt.2012.6.
Abstract
I argue here that gene patents, and patented genetic tests based on them, are a very bad idea. First, I discuss whether genes can reasonably be the subject of patents in the first place; I maintain that the answer is no. Second, I explain how gene patents interfere with scientific progress, slowing down the development of new cures and treatments for genetic diseases.
摘要
我在这里主张，基因专利以及基于这些专利的基因检测是一个非常糟糕的主意。首先，我将讨论基因是否能被合理地授予专利；我认为答案是否定的。其次，我将解释基因专利如何干扰科学进步，减缓治疗遗传疾病的新方法和新疗法的发展。
相似文献
1
The perils of gene patents.
Clin Pharmacol Ther. 2012 Jun;91(6):969-71. doi: 10.1038/clpt.2012.6.
2
Disease gene patents: overcoming unethical constraints on clinical laboratory medicine.
Clin Chem. 1999 Mar;45(3):324-30.
3
Exclusivity in testing for patented disease genes.
Mol Diagn. 1999 Mar;4(1):72-3.
4
How genetic variant libraries effectively extend gene testing patents: implications for intellectual property and good clinical care.
J Clin Oncol. 2012 Aug 20;30(24):2943-5. doi: 10.1200/JCO.2012.42.7757. Epub 2012 Jul 16.
5
Intellectual property. Patents on human genes: an analysis of scope and claims.
Science. 2005 Mar 11;307(5715):1566-7. doi: 10.1126/science.1105162.
6
Gene patenting--diagnosing the problem.
Lancet Neurol. 2002 Sep;1(5):267.
7
Patents to "treat me", no patents to "test me": an analysis of the 2009 Senate inquiry into gene patents.
J Law Med. 2010 May;17(5):800-6.
8
Gene patents can be ethical.
Camb Q Healthc Ethics. 1998 Fall;7(4):417-21. doi: 10.1017/s0963180198004125.
9
Genes and patent policy: rethinking intellectual property rights.
Nat Rev Genet. 2002 Oct;3(10):803-8. doi: 10.1038/nrg909.
10
Intellectual property. California moves shake up prenatal gene testing market.
Science. 2013 Nov 8;342(6159):680. doi: 10.1126/science.342.6159.680.
引用本文的文献
1
DREAMing of a patent-free human genome for clinical sequencing.
Nat Biotechnol. 2013 Oct;31(10):884-7. doi: 10.1038/nbt.2703.
2
Pervasive sequence patents cover the entire human genome.
Genome Med. 2013 Mar 25;5(3):27. doi: 10.1186/gm431. eCollection 2013.
本文引用的文献
1
Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 1986. 46: 705-716.
J Immunol. 2006 Dec 1;177(11):7485-96.
2
Intellectual property. Enhanced: intellectual property landscape of the human genome.
Science. 2005 Oct 14;310(5746):239-40. doi: 10.1126/science.1120014.
3
Population genetics of BRCA1 and BRCA2.
Am J Hum Genet. 1997 May;60(5):1013-20.
4
A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes.
Nature. 1986;319(6049):154-8. doi: 10.1038/319154a0.
Zotero 插件